Extended-release Buprenorphine Compared to Sublingual Buprenorphine in Rural Settings (RXR)
Conditions: Opioid-Related Disorders; Substance-Related Disorders; Narcotic-Related Disorders Interventions: Drug: Injectable extended-release buprenorphine; Drug: Sublingual buprenorphine-naloxone Sponsors: Yih-Ing Hser; National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH); The Emmes Company, LLC; University of California, Los Angeles; RAND; Cornell University; Oregon Health and Science University; University of Illinois at C hicago; University of Washington; West Virginia University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials